Advertisement
The Leading Source for Pharmaceutical & Biopharmaceutical Manufacturing News
Subscribe to Pharmaceutical Processing
View Sample

FREE Daily Email Newsletter

Chimerix Gets FDA OK to Test Drug for Ebola

October 17, 2014 11:39 am | News | Comments

Chimerix has received FDA clearance to proceed with a trial examining the safety and effectiveness of its brincidofovir tablets in patients who have the virus.               

TOPICS:

Noven Files Patent Infringement Lawsuit Against Actavis

October 17, 2014 8:50 am | News | Comments

The lawsuit was filed as a result of Actavis submitting an Abbreviated New Drug Application to the FDA in which Actavis is seeking approval to market and sell a generic version of Brisdelle® capsules prior to the expiration of the patents.  

TOPICS:

Aduro Expands Collaboration with Johnson & Johnson Innovation and Janssen for Lung Cancer Immunotherapies

October 17, 2014 8:40 am | News | Comments

Under the agreement, facilitated by the Johnson & Johnson Innovation center in California, Aduro will receive a $30M up-front payment and is eligible to receive significant development, regulatory and commercialization milestone payments up to a potential total of $817M.

TOPICS:
Advertisement

The Risk of Getting Ebola On a Plane

October 17, 2014 8:36 am | Videos | Comments

CNN talks to an infectious disease physician about the possibilities of becoming infected with Ebola on a flight.                       

TOPICS:

Nurses Infected With Ebola Being Treated With Experimental Drugs

October 17, 2014 8:26 am | Videos | Comments

Both Dallas nurses infected while treating an Ebola patient have been flown to better equipped facilities.                        

TOPICS:

Republicans Press for Ebola Travel Ban

October 17, 2014 8:19 am | by ERICA WERNER, Associated Press; MATTHEW DALY, Associated Press | News | Comments

House Republicans demanded a travel ban from Ebola-ravaged West Africa Thursday, calling it the only sure way to protect Americans from the virus's deadly reach. Administration officials resisted, as anxiety over the disease raced through the country and rattled the White House and Capitol Hill.

TOPICS:

Obama Weighs Ebola Czar; Texas Toughens Monitoring

October 17, 2014 8:06 am | News | Comments

Facing renewed criticism about the U.S. response to Ebola, President Barack Obama is conceding that it may make sense to have a single person lead the administration's effort. But he says imposing a travel ban from disease-ravaged West Africa, as Republicans have demanded, would be counterproductive.

TOPICS:

Nuvo Research Sells PENNSAID U.S. Rights to Horizon Pharma

October 17, 2014 8:01 am | News | Comments

Nuvo Research Inc. has completed the sale of its PENNSAID 2% U.S. sales and marketing rights to Horizon Pharma for a cash payment of US$45 million (CDN$50 million) which was payable on closing.          

TOPICS:
Advertisement

Sarepta Therapeutics Climbs on Ebola Vaccine News

October 17, 2014 7:56 am | by The Associated Press | News | Comments

Shares of Sarepta Therapeutics jumped 11 percent before the opening bell Friday after the drug developer said its potential Ebola treatment generated no safety concerns in early-stage human testing.         

TOPICS:

FDA Panel Votes to Keep Boxed Warning on Chantix

October 16, 2014 4:36 pm | by The Associated Press | News | Comments

Federal health advisers say a bold-letter warning about suicide risks with Pfizer's Chantix should remain on the anti-smoking drug until it can reevaluated based on new, rigorous study information. Eleven advisers to the Food and Drug Administration voted to retain the so-called black box warning.

TOPICS:

HHS Advances Development of Third Ebola Vaccine

October 16, 2014 3:39 pm | News | Comments

The development of a vaccine to prevent Ebola virus disease will be accelerated with support from the U.S. Department of Health and Human Services’ Office of the Assistant Secretary for Preparedness and Response (ASPR).      

TOPICS:

Lilly to Realign Puerto Rico Manufacturing Operations

October 16, 2014 3:28 pm | News | Comments

Eli Lilly and Company has announced plans to conclude production and pursue a sale of one of its three manufacturing plants in Puerto Rico. The manufacturing site, located in Guayama, Puerto Rico, will remain in operation until the end of 2015. 

TOPICS:

Overworked & Over-Caffeinated

October 16, 2014 3:22 pm | by Mike Auerbach, Editor In Chief | Blogs | Comments

It’s not big news that most of America is tired. Wherever your look people are yawning – in the car, in the office, in front of the TV – Americans seem to be tired all the time.            

TOPICS:

New Guidance for Early-Stage Lung Cancer Patients

October 16, 2014 8:50 am | Videos | Comments

Researchers in Texas say that removing the entire lung instead of part increases the chance of survival for early-stage lung cancer patients. Also, there more research linking psoriasis and high blood pressure.        

TOPICS:

FDA Approves Esbriet to Treat Idiopathic Pulmonary Fibrosis

October 16, 2014 8:41 am | News | Comments

Idiopathic pulmonary fibrosis is a condition in which the lungs become progressively scarred over time. As a result, patients with IPF experience shortness of breath, cough, and have difficulty participating in everyday physical activities.  

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading